Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
Mima, H
The risk is severe: if the courts find for the innovator, the generic manufacturer faces liability for the innovators lost profits, which for a blockbuster drug can reach into the billions of dollars
Getting these mixed up is the number one dosing error people make
Does glucagon-like peptide-1 (GLP-1) receptor agonist stimulation reduce alcohol intake in patients with alcohol dependence: study protocol of a randomised, double-blinded, placebo-controlled clinical trial
US$ 22.37
US$ 25.95
US$ 24.00
US$ 20.53
